Funding

Medi2data funding news – Healthtech Company Medi2data Secures £2.1Million in Funding

May 24, 2024 | By Team SR

UK-based healthtech company Medi2data secures £2.1million in funding under the Enterprise Investment Scheme (EIS). To make the process of securely and swiftly transferring medical data easier, the company has developed a range of digital goods and services.

UK-based healthtech company Medi2data secures £2.1million in funding under the Enterprise Investment Scheme (EIS). To make the process of securely and swiftly transferring medical data easier, the company has developed a range of digital goods and services.

For a variety of health risk evaluations, including life insurance underwriting, evaluating clinical research trial eligibility, reviewing personal injury cases, and evaluating an armed forces recruit's health, medical evidence is necessary.

It is anticipated that the current procedure for compiling and distributing medical records of consenting patients is still primarily manual and time-consuming, costing £180 million annually and requiring 850,000 days of labour from GP practitioners.

Built on the same clinical coding structure as government healthcare platforms in the UK and other important countries like the US, Australia, South Africa, and much of Europe, Medi2Data's platform is currently the only one of its sort. This implies that it can generate medical reporting more quickly, accurately, and systematically.

Read also - Rows funding news – Spreadsheet app Rows Secures €8 Million in Funding

Using unique technology, the business automatically redacts non-requested material from medical reports, protecting patient privacy in compliance with GDPR regulations.

Additionally, Medi2data offers a group of medical professionals who provide GP practices and their instructing clients with a fully outsourced medical reporting and triage service.

Medi2data provides pain management and condition-specific digital monitoring services to thousands of top insurers, Clinical Research Organisations (CROs), and Health and Retail providers.

According to Gayle Bowen, Director of Direct Investments at Wealth Club, Medi2Data is progressing remarkably in the field of healthcare technology.
In the upcoming year, sales are anticipated to double, and the company hopes to achieve sustainable profitability during this period.

Gayle Bowen, Director of Direct Investments at Wealth Club said: “Medi2Data is making impressive strides in the healthcare technology sector. Sales are expecting to double in the next 12 months and the company is aiming to reach sustainable profitability during this time.”

The proceeds from this round will be utilised to expand the company's workforce and infrastructure, enabling it to maintain and serve its multi-million pound pipeline in the UK and expand globally with the launch of Medi2Data S.A. in Cape Town, South Africa, among other initiatives.

About Medi2data

Medi2data they have built a suite of products and services to support GP Surgeries, Patients, and Instructing Parties in transacting medical data quickly and securely. Their mission is to transform the inefficient process of producing and obtaining medical evidence from GP Surgeries, for the benefit of the patient.

Recommended Stories for You